BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 15919466)

  • 1. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
    Alloway RR; Hanaway MJ; Trofe J; Boardman R; Rogers CC; Hanaway MJ; Buell JF; Munda R; Alexander JW; Thomas MJ; Roy-Chaudhury P; Cardi M; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):802-3. PubMed ID: 15848537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E;
    Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-free immunosuppression in pediatric liver transplantation: safety and efficacy after a short-term follow-up.
    Cintorino D; Riva S; Spada M; Minervini M; Sonzogni A; Foglieni CS; Gruttadauria S; Verzaro R; Henderson K; Aricò M; Gridelli B
    Transplant Proc; 2006 May; 38(4):1099-100. PubMed ID: 16757276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of race on the occurrence of posttransplant diabetes in kidney transplant recipients treated with early steroid discontinuation.
    Walczak D; Calvert D; Oberholzer J; Testa G; Sankary H; Benedetti E
    Transplant Proc; 2005 Mar; 37(2):819-21. PubMed ID: 15848543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.
    Tellis V; Schechner R; Mallis M; Rosegreen S; Glicklich D; Moore N; Greenstein S
    Transplant Proc; 2005 Mar; 37(2):906-8. PubMed ID: 15848571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC; Lalli CA; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):764-6. PubMed ID: 18455010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression.
    Sharma A; Minz M; Singh S
    Transplant Proc; 2008 Sep; 40(7):2414-5. PubMed ID: 18790252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ; Park JB; Kim YS; Kim SJ; Ha J; Kim HC; Kim SJ; Moon IS; Yang CW
    Transplant Proc; 2012 Jan; 44(1):115-7. PubMed ID: 22310592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.